Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
<p style="text-align:justify;"> <b>Background:</b> Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were to identify...
Hlavní autoři: | Griffiths, R, Gleeson, M, Knopf, K, Danese, M |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
BioMed Central
2010
|
Podobné jednotky
-
Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
Autor: Gleeson Michelle, a další
Vydáno: (2010-11-01) -
Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
Autor: Danese, MD, a další
Vydáno: (2016) -
Retrospective Evaluation of Patients Diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)
Autor: Atakan TEKİNALP, a další
Vydáno: (2020-12-01) -
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
Autor: Griffiths, R, a další
Vydáno: (2010) -
Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)
Autor: Roba M. Talaat, a další
Vydáno: (2014-01-01)